# Navigating cancer: Insights from patient journey mapping

**Authors:** Sarah Day, Jane Harries, Bukeka Sawula, Alec Payne, Shameem Bray, Denis Okova, Lauren Pretorius, Jennifer Moodley, Sogo France Matlala, Taiwo Opeyemi Aremu, Taiwo Opeyemi Aremu

PMC · DOI: 10.1371/journal.pone.0327113 · PLOS One · 2026-03-25

## TL;DR

This study uses patient journey mapping to understand the experiences of breast and cervical cancer patients in South Africa, aiming to improve healthcare systems.

## Contribution

The study introduces patient journey mapping as a method to center patient voices in cancer care, revealing systemic gaps and opportunities for improvement.

## Key findings

- Patient journey mapping highlights how relational and structural factors influence cancer care experiences.
- Self-advocacy and intersecting vulnerabilities shape patients' journeys through the healthcare system.
- The method provides actionable insights for redesigning more patient-responsive health systems.

## Abstract

Cancer is an increasing public health problem in South Africa, with breast cancer being the most diagnosed cancer and cervical cancer the leading cause of cancer deaths among women. Despite the complexity of breast and cervical cancer patients’ journeys through the healthcare system, patients’ voices are still predominantly missing from the body of literature. Patient journey mapping, as a qualitative research method, offers an opportunity for centring patients in their care journeys and reimagine healthcare provision for the potential improvement of health systems and patient outcomes.

The aim of this study was to map journeys of breast and cervical cancer patients across the cancer care continuum.

Using patient journey mapping, we conducted six focus group discussions with patients with breast and cervical cancer who had completed treatment in Gauteng, KwaZulu Natal and the Western Cape, South Africa. The process involved three steps: 1.) development of individual maps; 2.) narrative sharing; and 3.) development of a collective map. Results of the study were shared in feedback sessions.

A total of 31 people participated in the focus groups: 23 with breast cancer, 7 cervical cancer and one had both cancers during her lifetime. The participants’ ages ranged between 30 and 69 years old. A patient journey map was developed drawing on the individual and collective maps and participant narratives. The findings of the paper constellate around three themes. The first theme, (de)personalised care, offers an examination of how relational, institutional and structural factors shape and are reshaped through participants lived experiences across the cancer care continuum. The second theme, self-advocacy, explores how participants advocate for their healthcare needs throughout the cancer care continuum. The third theme, intersecting vulnerabilities, explores how intersecting social identities, such as socioeconomic factors, gender, comorbidities and mental health, shape their cancer care journeys.

By centring patient with breast and cervical cancer voices, patient journey mapping not only showed where services and systems fall short but also provided guidance for redesigning a more patient responsive health system.

## Linked entities

- **Diseases:** breast cancer (MONDO:0004989), cervical cancer (MONDO:0002974)

## Full-text entities

- **Diseases:** substance abuse (MESH:D019966), cervical cancer (MESH:D002583), weakness (MESH:D018908), Pain (MESH:D010146), stiffness (MESH:C566112), breast symptoms (MESH:D061325), lymphedema (MESH:D008209), numbness (MESH:D006987), diabetes (MESH:D003920), bleeding (MESH:D006470), infections (MESH:D007239), HIV (MESH:D015658), FGDs (MESH:D003057), death (MESH:D003643), brain fog (MESH:D005222), hypertension (MESH:D006973), Breast Cancer (MESH:D001943), breast, cervical, colorectal, prostate, lung, ovarian and skin cancer (MESH:D010051), hearing loss (MESH:D034381), TB (MESH:D014390), anxiety (MESH:D001007), autoimmune conditions (MESH:D001327), shock (MESH:D012769), Cancer (MESH:D009369), disability (MESH:D009069)
- **Chemicals:** Opeyemi (-)
- **Species:** Homo sapiens (human, species) [taxon 9606], Human immunodeficiency virus 1 (no rank) [taxon 11676]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13016344/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC13016344/full.md

## References

64 references — full list in the complete paper: https://tomesphere.com/paper/PMC13016344/full.md

---
Source: https://tomesphere.com/paper/PMC13016344